Polidocanol for endovenous microfoam sclerosant therapy. - Wikidata - wikimedia - TriplyDB

Polidocanol for endovenous microfoam sclerosant therapy.

Polidocanol for endovenous microfoam sclerosant therapy.

http://www.wikidata.org/entity/Q37456712

about

Acute renal failure, microangiopathic haemolytic anemia, and secondary oxalosis in a young female patient Interdisciplinary Management of Head and Neck Vascular Anomalies: Clinical Presentation, Diagnostic Findings and Minimalinvasive Therapies.A modified Tessari method for producing more foam.Embolosclerotherapy by the Transvenous Approach for Lower Extremity Arteriovenous Malformation in Cowden Syndrome: A Case Report.Mini-invasive high-tie by clip apposition versus crossectomy by ligature: Long-term outcomes and review of the available therapeutic options.Intraarterial polidocanol injection for the treatment of peripheral arteriovenous malformations.Size of Sclerosing Foams Prepared by Ultrasound, Mechanical Agitation, and the Handmade Tessari Method for Treatment of Varicose Veins.Evaluation of the Efficacy of Ultrasound-Guided Local Lauromacrogol Injection Combined with Aspiration for Cesarean Scar Pregnancy: A Novel Treatment.The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

P2860

Q33396335-7B939BD9-A4CD-4429-B28C-DA867366CBDA Q33690211-54A53449-65E1-46A2-A971-969E7382084E Q36599438-28409036-C9DF-465E-9887-07B147C44975 Q36727273-17C676D5-92AC-446B-A486-6D9FE75521FA Q38831445-0C9904FE-4DE7-4B84-B93F-D7FDC0A82B96 Q44527165-7B7FB2C8-552F-4EDC-8A5C-6A3CB4207097 Q47239926-D514207A-2AB6-429F-86E4-2E0F5B01AB5D Q47363043-561B0FC6-4C50-4062-B5A2-6A0E006C8975 Q51693129-3531A216-2B77-4B88-BA92-CF77F417C3AC

P2860

Polidocanol for endovenous microfoam sclerosant therapy.

http://www.wikidata.org/entity/Q37456712

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Polidocanol for endovenous microfoam sclerosant therapy.

@en

Polidocanol for endovenous microfoam sclerosant therapy.

@nl

type

label

Polidocanol for endovenous microfoam sclerosant therapy.

@en

Polidocanol for endovenous microfoam sclerosant therapy.

@nl

prefLabel

Polidocanol for endovenous microfoam sclerosant therapy.

@en

Polidocanol for endovenous microfoam sclerosant therapy.

@nl

P1433

Q37456712-A05A62EA-8F5B-42CB-BF84-F7CF8B81D49E

P1476

Q37456712-0D8A3266-0A4A-4BC7-901D-475D0D1EFA59

P2093

Q37456712-ADF0C52C-FC37-4AFF-936E-EEF2793EE606

P2860

Q37456712-0A1CBFF2-D406-4B68-BD65-DEF211D3BABA

Q37456712-0CAB8426-A2F2-4D1E-A48B-D34BF4C954BF

Q37456712-10C8CEBA-8127-4AA3-86C3-7AAC688BFA4F

Q37456712-16C0F6B1-C0AE-4BF7-8EDC-02D1D0DB1B83

Q37456712-1A00032D-A50F-49E9-BCC2-6B55D08D9156

Q37456712-2E156709-056C-46CB-941A-B97AC1DCC5E4

Q37456712-2F75BD32-7698-417F-A2C3-511830FF4E35

Q37456712-352E66C1-0DD3-4619-8958-05362373CC12

Q37456712-378E152E-3DBE-4496-B859-96BF8FC39351

Q37456712-3D15F8D2-8D2A-4711-ADFF-D675E851C1C1

P304

Q37456712-907B6F2E-7362-4756-BFBD-5129BBAC6A39

P31

Q37456712-ECB6BFB6-CF5B-4EB0-B19D-29DE2CBF898D

P356

Q37456712-D0626A70-74E8-4AEB-B26D-F6655584C8F7

P407

Q37456712-99C4DEA3-36B1-4F28-958E-755D022E64EE

P433

Q37456712-020CBAA3-304E-422B-9CB2-706D5D991F53

P478

Q37456712-02470C5D-ADCD-46ED-A015-43CBB4326220

P577

Q37456712-46B7048D-7C74-4128-BF9C-FB31224BDAAB

P5875

Q37456712-D1A937F8-E3A9-4FFC-BFC3-16322A669D3D

P698

Q37456712-2AFB9685-A0C4-4896-AEE4-06ABCD77612E

P932

Q37456712-9ADC5538-C60E-4591-B0C8-63A1E9013BE7

P356

13543780903376163

P1433

Expert Opinion on Investigational Drugs

P1476

Polidocanol for endovenous microfoam sclerosant therapy.

@en

P2093

David M Eckmann

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral gas embolism absorption during hyperbaric therapy: theory

Preliminary experience with a new sclerosing foam in the treatment of varicose veins.

Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques.

Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.

Complications of sclerotherapy.

Major neurological events following foam sclerotherapy.

Stroke after varicose vein foam injection sclerotherapy.

Treatment of venous malformations with sclerosant in microfoam form.

The epidemiology of chronic venous insufficiency and varicose veins.

Nomenclature of the veins of the lower limbs: an international interdisciplinary consensus statement.

P304

1919-1927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903376163

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38088065

http://www.w3.org/2001/XMLSchema#string

P698

19912070

http://www.w3.org/2001/XMLSchema#string

P932

2787977

http://www.w3.org/2001/XMLSchema#string